Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

BACKGROUND: New screening technologies and vaccination against human papillomavirus (HPV), the necessary cause of cervical cancer, may impact optimal approaches to prevent cervical cancer. We evaluated the cost-effectiveness of alternative screening strategies to inform cervical cancer prevention gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, E A, Ortendahl, J D, Sy, S, Kristiansen, I S, Kim, J J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341862/
https://www.ncbi.nlm.nih.gov/pubmed/22441643
http://dx.doi.org/10.1038/bjc.2012.94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341862/
https://www.ncbi.nlm.nih.gov/pubmed/22441643
http://dx.doi.org/10.1038/bjc.2012.94

Ejemplares similares